Custos Family Office’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$344K Sell
1,041
-150
-13% -$50.8K 0.23% 48
2025
Q3
$411K Buy
1,191
+80
+7% +$24.2K 0.23% 43
2025
Q2
$347K Buy
1,111
+128
+13% +$48.9K 0.11% 54
2025
Q1
$515K Buy
983
+331
+51% +$169K 0.18% 40
2024
Q4
$330K Sell
652
-3
-0.5% -$1.71K 0.12% 52
2024
Q3
$383K Buy
655
+1
+0.2% +$566 0.14% 44
2024
Q2
$333K Buy
654
+17
+3% +$8.33K 0.13% 46
2024
Q1
$315K Sell
637
-23
-3% -$11.7K 0.16% 37
2023
Q4
$347K Buy
660
+3
+0.5% +$1.6K 0.18% 34
2023
Q3
$331K Sell
657
-36
-5% -$17.7K 0.22% 30
2023
Q2
$333K Sell
693
-41
-6% -$20K 0.22% 31
2023
Q1
$347K Buy
734
+64
+10% +$30.9K 0.24% 28
2022
Q4
$355K Buy
670
+82
+14% +$43.4K 0.28% 27
2022
Q3
$297K Sell
588
-37
-6% -$19.5K 0.29% 19
2022
Q2
$321K Sell
625
-74
-11% -$37.2K 0.29% 15
2022
Q1
$356K Sell
699
-166
-19% -$80.1K 0.29% 16
2021
Q4
$435K Buy
+865
New +$392K 0.39% 20

Other funds holding UNH

Custos Family Office's UNH Position: Q4 2025 in Review

Custos Family Office reduced its UnitedHealth (UNH) stake by 13% in Q4 2025, selling an estimated $50.8K and leaving 1,041 shares worth $344K. The position accounts for 0.23% of the portfolio, ranked #48.

Custos Family Office first reported a position in UNH in Q4 2021 and has held it in 17 quarters since. The position peaked at $515K in Q1 2025. 3,296 funds tracked by Wall St. Rank hold UNH as of Q4 2025.

  • Custos Family Office held 1,041 shares of UnitedHealth worth $344K as of Q4 2025.
  • Custos Family Office sold 150 UnitedHealth shares in Q4 2025, an estimated $50.8K.
  • UnitedHealth made up 0.23% of Custos Family Office's portfolio in Q4 2025, its #48 holding.
  • Custos Family Office first reported a position in UnitedHealth in Q4 2021 and has held it in 17 quarters since.
  • Custos Family Office's UnitedHealth position peaked at $515K in Q1 2025.
  • 3,296 funds tracked by Wall St. Rank held UnitedHealth as of Q4 2025.

Based on Custos Family Office's 13F filing for Q4 2025, filed 17 Feb 2026.